Skip to Main Content

Author Details

Liyan Xue
Xuzhou Central Hospital
1996
192
27
PMIDPaper TitleJournal TitlePublished Year
36008639The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China.Surg Endosc2023
36371676Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic mutations.J Pathol2023
36008639The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China.Surg Endosc2023
36437350Comparison of the Clinicopathological Characteristics and Prognosis of Esophageal Squamous Cell Carcinoma with Intramural Metastases and Multiple Primary Carcinomas.World J Surg2023
37553667Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review.Diagn Pathol2023
36974732Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8+ T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China.Int J Surg2023
37087442Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.BMC Cancer2023
36972240Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.Am J Gastroenterol2023
36584672Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.Cancer Cell2023
37466146Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.Thorac Cancer2023
37078210[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China].Zhonghua Zhong Liu Za Zhi2023
36761760Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis.Front Immunol2023
36882775Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.BMC Med2023
37131252H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.Respir Res2023
36481651Mucoepidermoid carcinoma of the esophagus with MAML2 gene rearrangement: Case report and literature review.Pathol Res Pract2023
36748134[Value of direct immunohistochemical staining in assisting intraoperative frozen diagnosis of bronchiolar adenoma].Zhonghua Bing Li Xue Za Zhi2023
36693832Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.Signal Transduct Target Ther2023
37302386Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients.Oncol Res Treat2023
36990293A-to-I RNA-Editing: An Epigenetic Hallmark Cannot Be Ignored in Silencing the Tumor Microenvironment and Is Promising in Predicting Immunotherapy Response for Esophageal Squamous Cell Carcinoma.Gastroenterology2023
36675401The Feasibility and Safety of Endoscopic Submucosal Dissection for Circumferential Superficial Esophageal Squamous Cell Neoplasms.J Clin Med2023
37553667Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review.Diagn Pathol2023
37087442Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.BMC Cancer2023
36990293A-to-I RNA-Editing: An Epigenetic Hallmark Cannot Be Ignored in Silencing the Tumor Microenvironment and Is Promising in Predicting Immunotherapy Response for Esophageal Squamous Cell Carcinoma.Gastroenterology2023
37078210[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China].Zhonghua Zhong Liu Za Zhi2023
36974732Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8+ T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China.Int J Surg2023
37466146Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.Thorac Cancer2023
36972240Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.Am J Gastroenterol2023
37302386Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients.Oncol Res Treat2023
37131252H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.Respir Res2023
36882775Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.BMC Med2023
36748134[Value of direct immunohistochemical staining in assisting intraoperative frozen diagnosis of bronchiolar adenoma].Zhonghua Bing Li Xue Za Zhi2023
36693832Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment.Signal Transduct Target Ther2023
36584672Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.Cancer Cell2023
36437350Comparison of the Clinicopathological Characteristics and Prognosis of Esophageal Squamous Cell Carcinoma with Intramural Metastases and Multiple Primary Carcinomas.World J Surg2023
36675401The Feasibility and Safety of Endoscopic Submucosal Dissection for Circumferential Superficial Esophageal Squamous Cell Neoplasms.J Clin Med2023
36761760Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis.Front Immunol2023
36481651Mucoepidermoid carcinoma of the esophagus with MAML2 gene rearrangement: Case report and literature review.Pathol Res Pract2023
36371676Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic mutations.J Pathol2023
34013382Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.J Cancer Res Clin Oncol2022
36047973Comprehensive analyses of N<sup>6</sup> -methyladenosine-related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer.Cancer Sci2022
35530277The interaction of <i>p53</i> and DNA repair gene mutations and their impact on tumor mutation burden and immune response in human malignancies.Am J Cancer Res2022
35392225Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma.Front Oncol2022
36304092No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer.World J Gastroenterol2022
36098222Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis.J Pathol2022
35449073Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).J Exp Clin Cancer Res2022
36207607A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy.Br J Cancer2022
36131343CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration.BMC Urol2022
35615147RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma.Front Oncol2022
36257585A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.Int J Surg2022
36119493Dynamic monitoring revealed a slightly prolonged waiting time for total gastrectomy during the COVID-19 pandemic without increasing the short-term complications.Front Oncol2022
  • 1 - 50 of 384

Recommended Authors

Liubo Chen
The Second Affiliated Hospital of Zhejiang University
Career Start Year 2016
Number of shared co-authors 0
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Xing Wang
Shanghai Children's Hospital, Shanghai Jiao Tong University
Career Start Year 2011
Number of shared co-authors 1
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Lei Tang
Peking University Cancer Hospital and Institute
Career Start Year 2008
Number of shared co-authors 1
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 1
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Yue Yang
Peking University Cancer Hospital
Career Start Year 2005
Number of shared co-authors 1
Li Liu
College of Big Data & Software Engineering, Chongqing University
Career Start Year 2005
Number of shared co-authors 0
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Akihiro Sakai
Tokai University
Career Start Year 2002
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Min Gew Choi
Research Institute, National Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 0
Hongwei Zhang
General Hospital of Tibet Area Military Command
Career Start Year 1997
Number of shared co-authors 3
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 1
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Pengliang Wang
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Mee-Yon Cho
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Jae Ill Zo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Hideki Ueno
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 0
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Qimin Zhan
Peking University Cancer Hospital
Co-authored papers 25
Yongmei Song
Shandong University of Traditional Chinese Medicine
Co-authored papers 19
Zitong Zhao
School of Pharmacy, Wannan Medical College
Co-authored papers 12
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 8
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 7
Wen-Qiang Wei
Tianjin First Central Hospital, Nankai University
Co-authored papers 5
Leilei Zheng
Co-authored papers 3
Yongwei Yu
Changhai Hospital
Co-authored papers 3
Xin Yang
Peking University Cancer Hospital & Institute
Co-authored papers 2
Yan Zhang
Co-authored papers 2
James Godbold
Co-authored papers 1
Fei Fang
University of Pittsburgh
Co-authored papers 1
Dakshayani Lomada
Yogi Vemana University
Co-authored papers 1
Ellen R Richie
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Sung Eun Choi
Co-authored papers 1
Fan Zhang
Huaihe Hospital of Henan University
Co-authored papers 1
Zhonghe Sun
Jiangsu University
Co-authored papers 1
Peilin Zhang
Shandong Management University
Co-authored papers 1
Jami Willette-Brown
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Fang Fang
Co-authored papers 1
Feng Zhu
Basic Medical College, Qingdao University
Co-authored papers 1
Yinling Hu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Adam R Brentnall
Queen Mary Universityof London
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Dongxin Lin
Co-authored papers 1
Erin Moshier
Co-authored papers 1
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 1
Zane Gray
Tulane Cancer Center, Tulane School of Medicine
Co-authored papers 1
Cordelia Langford
Co-authored papers 1
Release 1.2